Skip to content
A LETTER FROM PURDUE REGARDING THE NEW OXYCONTIN 80MG
avatar
rjbeck77 posted:
This is a letter from Purdue Pharma.

October 4, 2010

Dear Healthcare Professional:
On April 5, 2010, the U.S. Food and Drug Administration (FDA) approved Purdue Pharma
New Drug Application for a reformulation of 80mg OxyContin
® (oxycodone hydrochloride
controlled-release) Tablets. Purdue elected to reformulate OxyContin to be bioequivalent to
the original formulation and in an effort to make the tablet more difficult to manipulate for
the purpose of intentional misuse and abuse, however, there is no evidence that the
reformulation of OxyContin is less subject to misuse, abuse, diversion, overdose, or addiction.
Since introducing reformulated OxyContin to the market on August 9, 2010, Purdue has
received reports that some patients are encountering diffi culties with swallowing
the reformulated tablet. Purdue encourages you to counsel your patients on
appropriately taking this medication and to remind them that:
"022 OxyContin Tablets should be taken one tablet at a time, with enough water to
ensure complete swallowing immediately after placing in the mouth
"022 Multiple tablets should not be swallowed together
"022 Tablets should not be dampened, soaked, licked, or otherwise wet prior to
placing them in the mouth for immediate swallowing

Regards RB
Reply


Featuring Experts

David N. Maine, MD is the director of the Center for Interventional Pain Medicine at Mercy Medical Center in Baltimore. Maine graduated with a degree ...More

Helpful Tips

want to know if anyone has gone threw the pain im having
got a bulgin disc between c5 c6 pain goes form my neck all down my spain threw my back... the lower part of my back is swollen.... have ... More
Was this Helpful?
2 of 13 found this helpful

Related News

There was an error with this newsfeed

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.